Juvenile atopic dermatitis models
    16.
    发明授权

    公开(公告)号:US11604184B2

    公开(公告)日:2023-03-14

    申请号:US16311378

    申请日:2017-06-23

    Abstract: The invention relates to biomarkers in children's skin, in particular in the skin of infants, the expression of which changes when the skin is affected by atopic dermatitis. Such markers are particularly advantageous in that they allow the skin's response to atopic dermatitis to be monitored. The inventors have developed methods for evaluating the in vitro efficacy of formulations in preventing the effects of atopic dermatitis on a child's skin, using a skin model specifically capable of reproducing the characteristics of children's skin.

    USE OF BIOMARKERS FOR EVALUATING THE EFFECTIVENESS OF ACTIVE INGREDIENTS
    19.
    发明申请
    USE OF BIOMARKERS FOR EVALUATING THE EFFECTIVENESS OF ACTIVE INGREDIENTS 审中-公开
    使用生物标记物评估活性成分的有效性

    公开(公告)号:US20160084822A1

    公开(公告)日:2016-03-24

    申请号:US14785212

    申请日:2014-04-22

    CPC classification number: G01N33/5023 G01N33/502 G01N33/5044 G01N33/6881

    Abstract: The invention relates to a method for evaluating the effectiveness of an active ingredient selected from C7 avocado sugars, also called avocado perseose, for preventing or treating a deficiency of the skin barrier, said method comprising the determination of the level of expression and/or activation of at least one biological marker, where said biological marker is selected from epidermal maturation markers, lipid barrier markers, hydric regulation markers and stratum granulosum regulation markers.

    Abstract translation: 本发明涉及一种用于评估选自C7鳄梨糖(也称为鳄梨坚果)用于预防或治疗皮肤屏障缺陷的活性成分的有效性的方法,所述方法包括测定表达水平和/或激活 的至少一种生物标志物,其中所述生物标志物选自表皮成熟标志物,脂质屏障标记物,水合调节标记物和颗粒颗粒调节标记物。

Patent Agency Ranking